Skip to main content
Erschienen in: Journal of Hematopathology 1/2020

20.11.2019 | Case Report

A case of an unusual lineage switch in late relapse ALL—is it actually a secondary leukemia?

verfasst von: Antonija Babić, Lejla Kurić, Klara Dubravčić, Zinaida Perić, Josip Batinić, Višnja Armanda, Dubravka Kuljiš, Drago Batinić

Erschienen in: Journal of Hematopathology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Acute lymphoblastic leukemia (ALL) is a malignant disease of lymphoid precursors. According to immunophenotype, it is further subdivided into precursor B cell ALL and precursor T cell ALL, with precursor B cell ALL being much more common both in children and adults. Lineage switch from one lymphoid lineage to another during the course of the disease is extremely rarely reported. Here, we describe a case of a child who initially presented as a precursor B-ALL but 15 years later and after two successfully treated relapses of the original ALL presented with early T cell precursor leukemia. Although it was considered as a relapse, it could be interpreted as a case of secondary leukemia, which can be explained as a consequence of treatment as well as a constitutional feature of an individual. Also, it draws attention to the possibility that hematopoietic cells, and in that context also leukemic cells, are much more plastic and capable of reprogramming than previously thought.
Literatur
1.
Zurück zum Zitat Dorantes-Acosta E, Pelayo R (2012) Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res 2012:1–18CrossRef Dorantes-Acosta E, Pelayo R (2012) Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res 2012:1–18CrossRef
2.
Zurück zum Zitat Ruiz-Delgado GJ, Nuñez-Cortez AK, Olivares-Gazca JC, Fortiz YC, Ruiz-Argüelles A, Ruiz-Argüelles GJ (2017) Lineage switch from acute lymphoblastic leukemia to myeloid leukemia. Med Univ 19(74):27–31 Ruiz-Delgado GJ, Nuñez-Cortez AK, Olivares-Gazca JC, Fortiz YC, Ruiz-Argüelles A, Ruiz-Argüelles GJ (2017) Lineage switch from acute lymphoblastic leukemia to myeloid leukemia. Med Univ 19(74):27–31
3.
Zurück zum Zitat Park M, Koh KN, Kim BE, Im HJ, Jang S, Park CJ, Chi HS, Seo JJ (2011) Lineage switch at relapse of childhood acute leukemia: a report of four cases. J Korean Med Sci 26(6):829–831CrossRef Park M, Koh KN, Kim BE, Im HJ, Jang S, Park CJ, Chi HS, Seo JJ (2011) Lineage switch at relapse of childhood acute leukemia: a report of four cases. J Korean Med Sci 26(6):829–831CrossRef
4.
Zurück zum Zitat Locatelli F, Schrappe M, Bernardo ME, Rutella S (2012) How I treat relapsed childhood acute lymphoblastic leukemia? Blood J 120(14):2807–2817CrossRef Locatelli F, Schrappe M, Bernardo ME, Rutella S (2012) How I treat relapsed childhood acute lymphoblastic leukemia? Blood J 120(14):2807–2817CrossRef
5.
Zurück zum Zitat Choi S, Henderson MJ, Kwan E, Beesley AH, Sutton R, Anita Y et al (2013) Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood. 110(2):632–639CrossRef Choi S, Henderson MJ, Kwan E, Beesley AH, Sutton R, Anita Y et al (2013) Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood. 110(2):632–639CrossRef
6.
Zurück zum Zitat Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM et al (2017) Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J 7(9):1–6CrossRef Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM et al (2017) Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J 7(9):1–6CrossRef
7.
Zurück zum Zitat Hijiya N, Ness KK, Ribeiro RC, Hudson MM (2009) Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer. 115(1):23–35CrossRef Hijiya N, Ness KK, Ribeiro RC, Hudson MM (2009) Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer. 115(1):23–35CrossRef
8.
Zurück zum Zitat Szczepański T, Willemse MJ, Kamps WA, Van Wering ER, Langerak AW, Van Dongen JJM (2001) Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy. Med Pediatr Oncol 36(3):352–358CrossRef Szczepański T, Willemse MJ, Kamps WA, Van Wering ER, Langerak AW, Van Dongen JJM (2001) Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy. Med Pediatr Oncol 36(3):352–358CrossRef
9.
Zurück zum Zitat Ganzel C, Devlin S, Douer D, Rowe JM, Stein EM, Tallman MS (2015) Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy. Br J Haematol 170(1):50–55CrossRef Ganzel C, Devlin S, Douer D, Rowe JM, Stein EM, Tallman MS (2015) Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy. Br J Haematol 170(1):50–55CrossRef
10.
Zurück zum Zitat Zuna J, Cavé H, Eckert C, Szczepanski T, Meyer C, Mejstrikova E, Fronkova E, Muzikova K, Clappier E, Mendelova D, Boutard P, Schrauder A, Sterba J, Marschalek R, van Dongen JJM, Hrusak O, Stary J, Trka J (2007) Childhood secondary ALL after ALL treatment. Leukemia. 21(7):1431–1435CrossRef Zuna J, Cavé H, Eckert C, Szczepanski T, Meyer C, Mejstrikova E, Fronkova E, Muzikova K, Clappier E, Mendelova D, Boutard P, Schrauder A, Sterba J, Marschalek R, van Dongen JJM, Hrusak O, Stary J, Trka J (2007) Childhood secondary ALL after ALL treatment. Leukemia. 21(7):1431–1435CrossRef
11.
Zurück zum Zitat Somasundaram R, Åhsberg J, Okuyama K, Ungerbäck J, Lilljebjörn H, Fioretos T, Strid T, Sigvardsson M (2016) Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states. Genes Dev 30(22):2486–2499CrossRef Somasundaram R, Åhsberg J, Okuyama K, Ungerbäck J, Lilljebjörn H, Fioretos T, Strid T, Sigvardsson M (2016) Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states. Genes Dev 30(22):2486–2499CrossRef
12.
Zurück zum Zitat Laiosa CV, Stadtfeld M, Xie H, de Andres-Aguayo L, Graf T (2006) Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity. 25(5):731–744CrossRef Laiosa CV, Stadtfeld M, Xie H, de Andres-Aguayo L, Graf T (2006) Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity. 25(5):731–744CrossRef
13.
Zurück zum Zitat Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell. 117(5):663–676CrossRef Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell. 117(5):663–676CrossRef
14.
Zurück zum Zitat Iwasaki H, Mizuno SI, Arinobu Y, Ozawa H, Mori Y, Shigematsu H, Takatsu K, Tenen DG, Akashi K (2006) The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev 20(21):3010–3021 Iwasaki H, Mizuno SI, Arinobu Y, Ozawa H, Mori Y, Shigematsu H, Takatsu K, Tenen DG, Akashi K (2006) The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev 20(21):3010–3021
Metadaten
Titel
A case of an unusual lineage switch in late relapse ALL—is it actually a secondary leukemia?
verfasst von
Antonija Babić
Lejla Kurić
Klara Dubravčić
Zinaida Perić
Josip Batinić
Višnja Armanda
Dubravka Kuljiš
Drago Batinić
Publikationsdatum
20.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Hematopathology / Ausgabe 1/2020
Print ISSN: 1868-9256
Elektronische ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-019-00371-x

Weitere Artikel der Ausgabe 1/2020

Journal of Hematopathology 1/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …